TMCI
Treace Medical Concepts, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.81
−1.43%Margins
Gross margin
79.5%
EBITDA margin
-22.0%
EBIT margin
-26.2%
Net margin
-29.0%
FCF margin
-12.2%
-87.9%
Return on equity
-32.9%
Return on assets
-38.3%
Return on invested capital
1.12x
Asset turnover
-$14.6M
Cash from operations
$0.70
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026